# Acorn Biolabs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/acorn-biolabs

- Industry: Biotechnology
- Headquarters: Toronto, Canada
- Website: www.acorn.me
- Total disclosed funding: $11M
- Latest round: Series A (Jan 31, 2024)
- Investors on record: 9

## About

Based in Ontario, Canada, and founded in 2017 by Chief Executive Officer Drew Taylor, Chief Information Officer Steven ten Holder, and co-founder Patrick Pumputis, Acorn Biolabs, Inc. operates healthtech based company providing take-home human cell cryopreservation service such as tissue engineering, and organ regeneration. In January 2024, Acorn Biolabs, Inc. raised CAD 11 million in series A funding led by new investor Merz Aesthetics, with participation from other new investors TELUS Ventures, MDE Investments, The Leslie Group, and Lee Li Holdings. Individual investors also participated in the round. 

Acorn Biolabs, Inc. develops customized regenerative medicines for patients by accessing the cells, analysis and cryopreservation, and cell based topical treatment. The company offers preserved stem cells for future regenerative treatments, including both therapeutic and aesthetic applications. In addition, the firm focuses on anti-aging through treating the cells in human body, which have potential to rejuvenate skin, replenish hair, and other disease. 

The company plans to use the funding from January 2024 to increase the size of our business activities in the United States and Canada and to conduct further research and development on regenerative aesthetic applications.

## Funding rounds

- Series A, Jan 31, 2024, $8.2M — TELUS Ventures, Merz Aesthetics, MDE Investments, The Leslie Group, Lee Li Holdings
- Seed, Jan 16, 2019, $3.3M — Real Ventures, Epic Capital Management, Pool Global Partners, Globalive Technology Inc.

## Investors

- Real Ventures — Seed
- Epic Capital Management — Seed
- Pool Global Partners (https://capitalatlas.ai/funds/pool-global-partners) — Seed
- Globalive Technology Inc. — Seed
- TELUS Ventures (https://capitalatlas.ai/funds/telus-ventures) — Series A
- Merz Aesthetics — Series A
- MDE Investments — Series A
- The Leslie Group — Series A
- Lee Li Holdings — Series A